The chemical class referred to as KGA_Gls Activators encompasses a diverse array of compounds, which, while not directly interacting with KGA_Gls (Kidney-type glutaminase), modulate its activity through various cellular mechanisms and pathways. These activators are not a homogenous group but rather a collection of chemically distinct entities that converge on the common endpoint of enhancing the function of KGA_Gls. This enhancement often occurs indirectly, through the modulation of upstream signaling pathways, substrate availability, or other metabolic processes that ultimately lead to increased KGA_Gls activity.
Among these activators, some work by modulating the availability of substrates essential for the enzymatic activity of KGA_Gls. For instance, certain amino acids like L-glutamine, when present in abundance, can lead to an increase in KGA_Gls activity simply by being readily available for conversion. Others operate through more complex intracellular signaling cascades; growth factors such as EGF (Epidermal Growth Factor) and TGF-α (Transforming Growth Factor-alpha) activate receptors that initiate a series of downstream events resulting in the upregulation of KGA_Gls. Similarly, compounds that influence the mTOR or AMPK pathways can have downstream effects on KGA_Gls activity, as these pathways are intimately connected to cellular metabolism and energy balance. Additionally, activators like retinoic acid, which is known to influence cellular differentiation and metabolism, may also indirectly impact KGA_Gls activity. Modulators of cellular energy status, such as AMPK activators, reflect the cell's adaptive response to energetic demands and can influence glutaminolysis, and hence KGA_Gls activity, as part of this response. Moreover, various compounds that influence cellular redox status, including NRF2 activators, might also affect KGA_Gls indirectly, as changes in redox balance can lead to a reconfiguration of metabolic pathways, including those involving glutaminolysis. Collectively, these KGA_Gls activators constitute a chemical class characterized by their diverse structures and mechanisms but unified by their common influence on the KGA_Gls enzyme and glutaminolysis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin can modulate metabolic pathways which might indirectly increase KGA activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can influence cellular differentiation and metabolic pathways, potentially upregulating KGA. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $62.00 | ||
An amino acid that can upregulate mTOR, which in turn might influence KGA activity. | ||||||
L-Glutamine | 56-85-9 | sc-391013 sc-391013C sc-391013A sc-391013D sc-391013B | 100 g 250 g 1 kg 5 kg 10 kg | $37.00 $47.00 $99.00 $379.00 $733.00 | 2 | |
Exogenous glutamine can potentially increase KGA activity by substrate availability. | ||||||